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We investigated the responses of normal and sclero-
derma fibroblasts to various growth factors, espe-
cially transforming growth factor-{31 (TGF-/31). The 
effects of various growth factors on (3H]thymidine 
incorporation in normal and scleroderma fibroblasts 
were examined. (1251]-labeled platelet-derived 
growth factor (PDGF)-BB binding in scleroderma and 
normal fibroblasts was examined both in the presence 
and absence of TGF-/31 (1 ng/ml). Cytoplasmic pro-
tein was isolated and analyzed by Western blotting. 
Total RNA from fibroblasts was also isolated and 
analyzed by reverse transcriptase-polymerase chain 
reaction (RT-PCR) using specific primer sets. Mito-
genic responses to TGF-{31 (0.33-1 ng/ml) in seven 
scleroderma fibroblast strains were significantly 
greater than those in normal controls. [1251]-PDGF-
BB binding to scleroderma fibroblasts was increased 
C ultured fibrob lasts derived from early affected skin lesions in scl erodem1a [systemic sclerosis (SSe)] express a phe notype di.fferent from that of normal fibroblasts. Characteristics of this phenotype include enhanced mRNA expression of several extracellu lar 
m atrix genes [1] and an activated transcriptional level of collagen 
gene expression [2]. Our recent studies also indicate that sclero-
d erm a fibroblasts exh.ibit a distinctive upregul ation of pla telet-
d e rived growth fac tor (PDGF)-a receptors afte r transforming 
growth factor-,81 (TGF-,81) stimulation as compared to normal 
fibroblasts [3]. [n contrast , TGF-(3 upregulated th e mitogenic 
responsiveness to b as ic fibrob last growth factor (bFGF) only in 
adult normal fibrob lasts and not in sclerode nna fibroblasts [4]. We 
also observed an increased growth response of sclerodenna fibro-
blasts to TGF-(31 itself [5] . However, TGF-(31 h as been shown to 
b e an indirec t mitogen for human fibroblasts acting through PDGF 
or PDGF-likc peptides [3 ,6,7]. In thi s study, we confirm ed that 
scleroderma fibrob lasts had a greater g rowth response to TGF-(31 
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after TGF-{31 stimulation. The increased response to 
TGF-/H was shown to be mediated through PDGF-
like protein induction; TGF-{31-treated scleroderma 
fibroblasts produced greater amounts of 36-kD 
PDGF-like protein, which was reported previously as 
connective tissue growth factor (CTGF), than did 
TGF-{31-treated normal fibroblasts. TGF-/31 treat-
ment also upregulated PDGF-0' receptor expression 
in scleroderma fibroblasts but not in normal dermal 
fibroblasts. mRNA expression of CTGF and PDGF-0' 
receptor was correlated with the above protein ex-
pression. These observations suggest that the in-
creased growth response to TGF-{31 in scleroderma 
fibroblasts is mediated through the induction of 
CTGF and PDGF-0' receptor. Key JVords: systemic scle-
rosislcmmective tissue growth factor/platelet-derived g•·owth 
factor l'eceptor. J Invest D ennatol 105:128-132, 1995 
th an normal fibroblasts and clarified the m ech anism of tlus in-
creased responsiveness to TGF-(31. 
MATERIALS AND METHODS 
Cell Cultures Fibroblasts were obtained by skin biopsy from affected 
forearm skin of seven female J apanese patients, with diffuse cutaneous SSe 
with less than a two-year duration of skin thickening, who fu lfilled the 
American Rheumatism Association crite ria for diagnosis [8]. Control fibro-
blasts were obtained by biopsy from healthy donors ma tched with each SSe 
patient according t.o sex, age, and biopsy site and they were processed in 
parallel. The cells were cultured in minimum essential medium (MEM) 
supplemented with 10% fe tal bovine serum (FBS) . Cell s at the third or 
fourth passage were used for experiments. Human umbili cal vein endothe-
lial cell s (HUVEC) were obtained from Kurabo (Osaka, Japan) and grown 
in endothelial growth medium (EGM) (Kurabo) containing 2% FBS. 
Incubation was perfom1ed in T75 Rasks at 37°C in 95% air and 5% C02 . 
Growth Factors T he growth f.1cto rs used were recombinant PDGF-AA 
homodimcr, recombinant PDGP-BB homodimcr, recombinant epidermal 
growth factor (EGP). and TGF-J31 purified from human plate lets, aU of 
which were purchased from R &D Systems Inc. (Minneapolis, MN) . 
Growth Assays ([3H)Thymidinc Incorporation Assays) T he cells 
(2 X 10'1/ wcll) were placed in 24-well plates in MEM with to•;., PBS and 
grown to conRuency. They were washed with phosphate buffered-sa line 
(PBS) once and incubated for 24 h in MEM with 0.1 1\'h bovine serum 
albumin (serum-free medium; SFM). The ce ll s were then stimulated with 
growth f:1ctors for 24 h in the absence of serum, labeled with 0.5 ml of 
r3 H]thymidine (final concentration 1 tJ.Ci/ml; N ew England Nuclear, 
Boston , MA) fo r 2 h , and then washed three times with cold PBS and four 
0022-202X/95/S09.50 • SSDI0022-202X(95)00158-H • Copyright © 1995 by T he Society for Investigative Dermatology, l.nc. 
128 
VOL. 105, NO. 1 JULY 1995 GROWTH R ES PO NSE TO GROWTH FACTORS IN SCLERODERMA FIBROBLASTS 129 
times with 5'Yo trichloroacetic acid. Five hundred microliters of 0.1 N 
NaOH/ 0.1% sodium dodecylsulfate (SDS) was added, and the radioactivity 
was measured in 5 ml of aq ueous counting scintillant l1 (ACS II) (Amer-
sham, Arlington Heights, !L) using a liquid scintillation system. All exper-
iments were performed in triplicate . In some wells, 10 f.Ll of the polyclonal 
anti-PDGF IgG (Becton Dickinson , Bedford, MA) was added at the time of 
iocubation with growth f.1ctors. 
[ 12si]-Labclcd PDGF-BB Binding Assay [ 1251)-labe led PDGF-BB was 
purchased fi·otn N ew England Nuclear (specific activ ity 46 !J.C i/ mg). After 
tryps inization, the cells (2 X 1 O" /well) were placed in 24-well culture plates 
io MEM with 10% FBS. grown to confluency, and incubated for 24 h in 
serum-free medium . After stimulation with or without TGF-/31 (1 ng/ ml) 
for 8 h, the cells were incubated with various concentrations of [1251)-
labeled PDGF-BB (0.125- 8 ng/ml) for 2 hat 4°C. Binding was de termined 
with (1251]-labeled PDGF-BB according to Bowen-Pope and Ross [9). Two 
wells from each plate were used for determining cell number. The other 
cells were then washed three times with PBS and harvested with solubili-
zation buffer, and total cell-associa ted (1251] was determined . Nonspecific 
binding was determined by addition of a hundredfold excess of unlabeled 
PDGF-BB. Scatchard analysis was performed, and receptor number was 
calculated according to the fo llowing fommla : receptor number = 
(R1 )(2 X 10- ·•)(6.023 X 1023)/cell number, where R1 = x-intercept from 
Scatchard plot M/ L, 2 X 10-'' = reaction volume in liters , and 6.023 X 1023 
= Avogadro's number. 
Immunoblotting Analysis Using Anti-PDGF a and !3 Receptor 
Antibodies The cells (2 X 106 / dish) were placed in 1 O-cm2 dishes in 
MEM with 10% FBS, grown to confluency, and then cultured with or 
without 1 ng/ ml ofTGF-!31 in SFM for 24 h. The cells were washed twice 
with cold PBS, harvested by gently scraping tl1e di shes witl1 a rubber 
policeman, and solubilized in l 00 f.Ll / 1 07 cells of cell lysis buffer (10 mM 
Tris-HC l, pH 7 .4, 3 mM phenyltnethylsulfo nyl fluoride, 1% Triton X-100) . 
The lysates were kept on ice fo r 15 min , transferred into microfuge tubes, 
and spun at 20,000 X g for 10 min. The supernatants were collected and 
used as samples . T he cell lysates of 1 X 10(' cells were subjected to 
e lectrophoresis on 7.5% SDS polyacrylamide gels. Proteins were electro-
transferred fi·om the gels to nitrocellulose sheets, which were then incu-
bated with polyclonal anti-PDGF-a receptor IgG (Upstate Biology Inc., 
Lake Placid, NY) o r anti-PDGF-!3 receptor lgG (Upstate Biology Inc.) for 
3 h. Filte rs were then incubated with alkaline phosphatase-conjugated goat 
anti-rabbit IgG antibody (Cappel, Durham, N C) for 1.5 h, and co lor was 
developed with 5-bromo-4-chloro-3-indolyl phosphate (Sigma, St. Louis, 
MO) and nitroblue tetrazolium (Research Organics, C leveland, OH). 
Immunoblotting Analysis Using Anti-PDGF IgG The above lysates 
ofl X 106 cell s were subjected to electrophoresis on SDS/10-20% gradient 
polyacrylamide gels and electrotrans ferred onto nitrocellulose sheets for 
io1munoblotting analysis. The nitrocellulose sheets were first incubated 
with anti-PDGF IgG for 3 h and then with alkaline phosphatase- conjuga ted 
rabbit an ti-goat lgG (Cappel) for 1.5 h. Color was developed as above. 
Reverse Transcriptase-Polymerasc Chain Reaction (RT-PCR) 
RT-PCR was performed using a GeneAmp RNA PCR kit (Perkin Elmer 
Cetus, Norwalk, CT) according to the manufacturer's instructions . Briefly, 
total RNA from normal and scleroderma fibroblasts witl1 or without 
TGF-!31 (1 ng/ ml) stimulation for 4 h or from HUVEC was isolated by the 
guanidium thiocyanate method [10). Each 1 1-1g of total RNA was reverse 
transcribed using random hexamer primers. For eDNA amplification , PCR 
was perfom1cd for 30 cycles. The eDNA concentration was first normalized 
by the expression of glyceraldehyde 3-phosphatc dehydrogenase (G3PDH). 
The primers used were 5'S primer, nucleotides 71-96, and 3' AS primer 
n ucleotides 1030-1053 [11] , which yielded a 983 base pair (bp) product. All 
the primer sets used in tlus experio1ent were designed so that at leas t one 
intron was located in the corresponding genomic sequence to detect 
possible amplification of any contaminating genomic DNA. Eight primer 
se ts based on published sequences o f human PDGF-A chain , PDGF-B chain, 
connective tiss ue growth factor (CTGF) , and PDGF-a receptor were as 
fo llows: for the PDGF-A chain , S'S primer, nucleo tides 898 -925 , and 3 ' AS 
primer nucleotides 1175-1201 [1 2), PCll... product 304 bp; for the PDGF-B 
chain , S'S primer, nucleotides 1401-1432 and 3 ' AS primer, nucleotides 
1621-1 653 (13), PCR product 253 bp for the CTGF, 5'S primer , nucle-
o tides 911-929, and 3 'AS primer nucleotides 11 60 -11 80 [7), PCR product 
270 bp, and for the PDGF-a receptor, 5 'S primer, nucleotides 1350-1369 
and 3'AS primer, nucleotidcs 1682-1701 [1 4), PC R product 352 bp. The 
RT-PCR products were separated by agarose gel electrophoresis and 
visualized by ethidium bromide staining. 
Semiquantification of Gene Expression By PCR Changes in CTGF 
and PDGF-a receptor gene expression were es timated by PCR. The eDNA 
Table I. Sclerodertna Fibroblasts Show Greater 






NS (n = 7) 
274 ::':54% 
789 ::': 178% 
142 ::': 25% 
422 ::': 85% 
SSe (n = 7) 
224 = 29% 
722 ::': 167% 
241 ::': 35%1' 
242 ::': 45%1' 
f) Confluent cells made quiescent b)' serum dcp1;v:1tion were stimulated with 
POGF-AA (25 ng/mi), PD GF-BB (25 ng/ml) , TGF-{3I ( I ng/mi), and EGF (10 
ng/ml) for 24 h. Cells were labeled fo r 2 h with 1 J.LCi / ml of l' Hlthymidine. Each 
experiment was pe rformed in triplicate wcUs. 1"3 1-l] thymidinc incorpor;ttion (cpm) in 
the we lls without growth f.1ctors was set at l OO (X, fo r each group. Each value represents 
the mean ± SD for seven norm<~ I skin fibroblast (NS) and seven sclerodermil fibrobla st 
(SSe) strains. 
"Values significantly greater than control fibrob lasts, by Mann-Whin1 cy U test. P < 
0.05. 
concentration was first nomulized by the expression of G3PDH. For 
quantifi ca tion . 2 tJ.C i of dCTP was added in the reaction mix ture , an d 
eDNA concentrations of di fle rent batches were compared. eDNA derived 
from 150 ng of tota l RNA was prepared and diluted 1:2, 1:4, 1:8, 1:16. and 
1:32 in water. The PC R products were electrophoresed in a 2% agarose gel 
and the 983-bp bands excised, and the radioactivity incorporated into tl1e 
DNA was measured by Cerenkov scintil.lation counting. A standard curve 
was drawn from the radioactivities. The relative quantity of tl1 e expressed 
G3PDH gene in the eDN A was thus calcu.lated and normali zed by a 
standard curve. Similar experiments w ere done using the above specific 
primers for CTGF and PDGF-a receptor gene to determine relative 
expression of the two genes in comparison with corresponding GJPDH 
expression . 
Statistics We used the Mann-Whitney U tes t o r Wilcoxon's paired test 
for the statistical analyses . 
RESULTS 
Mitogenic Response to TGF-/31 in Scleroderma Fibroblasts 
Is Elevated First, we investigated the growth responses of 
nonnal and scleroderma fibrob lasts at th e thi rd passage co various 
growth fac tors: PDGF-AA (25 ng/ ml), PDGF-BB (25 ng/ml) , 
TGF-/31 (1 ng/ ml), and EGF (10 ng/ ml) . T h e con cen trations of aU 
the growth f.'lctors described above were sh own to have nearly 
maximal e ffec t in pre liminary experime nts (data not shown). T he 
m ean ± SD ofeHJthymidine incorporatio n (cpm) in the wells tha t 
received no growth t'itctors was 23 2 ± 18 cpm/ well in normaJ 
fibroblasts and 215 ± 25 cpm/weU in scleroderm a fibrobl asts (no 
signifi cant differe n ce). T h e eHJthymidine incorporation in wells 
with o ut g rowth fac tors for each g roup was set at 1 00% , and values 
for growth-f.>ctor-stimulated cells were re presented as a ratio 
against the wells without growth fa c tors. The m ean ::': SD of cells 
treated with each growth fa ctor in control and scleroderma fibro-
blasts is shown in Table I. The mitogenic response to TGF-/31 in 
scle roderma fibroblasts was significantly g rea te r than that in n ormaJ 
fibrobl as ts (241 ± 35°;(, versus 142 ± 25%, p < 0 .05). In contrast, 
there was no significant difl:ere n ce between these two g ro ups when 
the cells w e re trea ted with PDGF-AA or PDGF-BB. The mitogenic 
response to EGF in scleroderma fibroblasts was less than that in 
control fibroblasts . As sh own in Fig 1 , the mitogenic response to 
TGF-/31 (0.1-10 ng/ ml) b ecame maxin1al when the con centration 
of TG.F-/31 was 1 ng/ ml in both con t rol and scleroderma fibro-
blasts. Scleroderma fibroblasts showed significantly greater mito-
gen.ic responses than nom1al controls when TGF-{31 was added at 
0 .3 3 and at 1 ng/ ml. Anti-PDGF IgG (1:50) block ed the mitogenic 
e ffect of PDGF-AA both in control and scleroderma fibroblasts 
(Table II). Moreove r , anti-PDGF IgG significantly block ed th e 
mitoge nic effect ofTGF-{31 in scle rode rma fibrobla sts (168 ± 12% 
ve.rsus 102 ± 6%, p < 0.05) . T h e control mitoge nic response co 
TGF-{31 in sclerode rma fibroblasts in these blocking experiments 
was rather low compare d to that in the same ex"]Jeriments in Table 
I , probably because we used the fibroblasts at the fourth passage. 
Sclerode rma fibroblasts reproducibly showed significantly g rea ter 
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Figure 1. Scleroderma fibroblasts reveal increased mitogenic re-
sponse to TGF-/31 compared with normal fibroblasts. Confluent ce ll s 
made quiescent by serum deprivation were stimulated with va rio us concen-
trations of TGF-{31 for 24 h. TGF- {31 was added in 0.5 ml of serum-free 
medium. Cell s were labeled for 2 h with [3 H)thymidine. Each experiment 
was perfom1ed in trip ljca te wells. [3 H)thymidine incorporation (cpm) in the 
wells without growth factors was set at 1 oo•;., for each group. Each value 
represents the mean ::':: SD of seven normal (D ) and seven sclerodenna 
fib roblast strains (+). *, p < 0.05 compared to control fibroblasts at the 
same concentration of TGF-{31. 
response to TGF-/31 without anti- PDGF IgG compared to normal 
fibrobJa sts (168 ::': 12% versus 133 ::': 12%, p < 0.05). 
PDGF-a Receptor Is Overexpressed in Scleroderma Fibro-
blasts We investigated w hether this increased response to 
TGF-/31 was mediated through increased expression of the PDGF 
receptor on the ceil surface or the increased induction ofPDGF or 
PDGF-like peptides by TGF- /31. First, we conducted the C25l]-
labeled PDGF-BB binding assay in th ree pairs of normal and 
scle rodenna fibroblast strains. PDGF-BB is known to bind to all 
three PDGF receptor dim ers. As shown in Table III, we found a 
significan t 1.5- fo ld increase in PDGF-BB binding sites on sclero-
dem1a fi brobl asts afte r TGF-/31 (l ng/ml) stimulation (1.98 ::': 
0.21 X 105/ cell versus 2.97 ::': 0.25 X 105 /cell, p < 0.05), whereas 
no signifi ca nt increase of receptor number was o bserved in normal 
fibrobla sts after TGF-/31 stimulation . Second, we confirmed the 
increased expression of PDGF-a receptor subunit by immunoblot-
ting ;malysis. T he amount of PDGF- a receptor subunit in three 
Table II. Anti-PDGF IgG Blocks the Mitogenic Effect by 
TGF-/31 in Normal and Scleroderma Fibroblasts 
PDGF-AA" 
PDGF-AA + anti-PDGF IgG 
TGF-{31 
TGF-{31 + anti-PDGF IgG 
NS {n = 3) 
254 ::':: 42%, 
102 ::':: 12'X/' 
133 ::':: 12% 
101 ::':: 5% 
SSe {n = 3) 
234 ::':: 22% 
105 ::':: 6%1' 
168 ::':: 12% 
102 ::':: 6%1' 
'' Confluent cells made quiescen t by serum deprivatio n were stim ulated w ith 
PDGF-AA (25 ng/ml) and TGF-{31 (I ng/ml) with or without the addition of 
anti- PDGF lgG (1 0 jLl , I :50) for 24 h. Cells were la beled for 2 h with [3 1-!]thymidine. 
Each experi m ent was pcrfom1cd in trip licate wells. [3 1-J Jthymidinc incorporation (cpm) 
in the wells witho ut growth factors was set at l 00% for each gro up . Each value 
represe nts the me:m ± SD for three norma l skin fib roblast (NS) and three sclcrodenna 
fibroblast (SSe) strains. 
"Valu es signi fi cantly greater than corresponding values without anti-PDGF lgG by 
t in! paired W ilcoxon's test, p < 0.05. 
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Table III. TGF-/31 Increases [12 5 1]- PDGF-BB Binding to 
Scleroderma Fibroblasts 
TGF- {31 Receptor Number per Cell 
Cell strains Stimulation Kd (pM) {X 105) 
NS (n = 3)" 87 ::':: 1'1 1. 98 ::':: 0 .20 
+ 86 ::':: 10 2.06 ::':: 0.46 
SSe (n = 3) 82 ::':: 16 1. 98 ::':: 0 .21 
+ 87 ::t 13 2.97 ::':: 0.25" 
" Ce lls were plated and grown overn ight in 1 oo;;, FDS in 24-wc ll plates, fo llowed by 
24-h in cubation in serum-free medium. Cells were then incubutcd with or without 
TGF-{31 ( I ng/ml) for 8 h . Cell s were washed and J125 1J- I' DGF-BB bind ing assays 
were performed as described in A'la teriflls am/ J\ll ctltt)fk Va lues represen t mean ± SD of 
Kd and receptor number pe r cell from 3 normal skin fibrob las t (NS) and 3 sdcrodcnna 
fibrob last (SSe) strain s by Scatchard analysis. 
11 Va lues significant ly greater than corrcspondi11 g values wi tho ut TGF-/31 stimu lation 
by the pa ired Wilcoxon's rest, p < 0.05. 
sclerode rma fibroblast strains with TGF-/31 stimul ation was 3 .5 ::': 
1.4-fold higher than that without stimu lation, as measured densi-
tometricaUy (Fig 2) . There was no significant increase (1.1 ::': 
0.5-fold) in PDGF-/3 receptor expression in scleroderma fibrob lasts, 
nor any significant change in PDGF-a o r -/3 receptor expression 
(1.2 ::': 0.4 and 1.1 ::': 0.3- fo ld , respective ly) in normal fi broblasts 
induced by TGF-/31 stimulation. In parallel, we conducted R T-
PCR using specific primers for PDGF-a receptor; expression of 
PDGF- a mRNA was observed in both scleroderma and no rmal 
fibroblasts, but not in HUVEC. HUVEC is known to express 
PDGF and CTGF, bu t not PDGF receptor [7,12 ,13] . PDGF-a 
receptor mRNA expression in scleroderma fibro blasts was signifi-













Figure 2. TGF-{31 increases PDGF-a receptor and 36-kD PDGF-
like protein levels in scleroderma fibroblasts. Confluent cells were 
stimulated with TGF- ,£31 (1 ng/ ml) for 24 h. Lysatcs of 1 X 1 O'' cell s were 
subjected to electrophoresis on 7 .5% SDS (anti-PDGF-a and - {3 receptor) 
or 1 0-20'!/u grad ien t polyacrylamide ge ls {anti-PDGF) and analyzed by 
Westcm immunoblot analysis. - , witho ut addition of TGF-,£31, + , with 
TGF-{31 (1 ng/ml) stimulation. Similar results were obt:1ined in two additional 
expcrin1c nts. 
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Figure 3. mRNA expression of CTGF and PDGF-a receptor in 
scleroderma fibroblasts after TGF-{!1 stimulation is greater than in 
normal fibroblasts. Total l"tNA fi-om normal and scleroderma fibroblasts 
with or without TGF-/3"1 (J ng/ml) stimulation for 4 h or from HUVEC was 
extracted. Each 1 JLg of total RNA was reverse traus.:ribed using random 
bexarncr primers. For eD NA amplification, PCR was performed for 30 
cycles. Express ion of G3PDH, PDGF-A chain , PDGF-B chain, CTGF, and 
PDGF-a receptor (PDGF a-R.) mR.NA in normal (NS) and scleroderma 
(SSe) fibroblasts and HUYEC was shown. mRNA was amplified by 
RT-PCR using specific primers. The predicted sizes for the amplification 
products were G3PD J-I , 983 bp; PDGF-A chain, 304 bp; PDGF-B chain, 
253 bp; CTGF, 270 bp and PDGFaR., 352 bp. M, the base pair marker 
(cf>Xl74/ J-Iae Ill digest) was included in the ethidium bromide agarosc ge l. 
Similar results were obtained in two additional experiments . 
Table IV (3.1 ± 0.4-fold versus 7.8 ± 2.2-fo ld, p < 0.05). 
PDGF-a receptor expression in normal fibroblasts did not signifi-
ca ntly change after TGF-j31 stimulation (2.8 ± 0.6-fold versus 
2. 7 ± 0.5-fold). 
PDGF-Like Protein Is Induced By TGF-{31 Because TGF-J31 
is known to induce the production of CTGF protein, which reacts 
with anti- PDGF lgG , in normal skin fibroblasts [7,1 5]. we investi-
gated whether the increased mitogenic response to TGF- j31 ob-
Table IV. Scleroderma and Normal Fibroblasts Differ in 
the Effect of TGF-{31 on CTGF and PDGF-a Receptor 
mRNA Expressions 
TGF-{31 CTGF mR.NA 
Cel.l Strains Stimulation Expression (fold) 
NS (n = 3f' 0.11 :'::: 0.04 
+ 3.2 :'::: 1.9 
SSe (n = 3) 0.10 :'::: 0.03 
+ 10.8 :'::: 3.61' 
PDGF-a R.eceptor mRNA 
Expression (fold) 
2.8 :'::: 0.6 
2.7 ::!: 0.5 
3.1 :'::: 0.4 
7.8 :'::: 2.21' 
• TGF-/31 ( I ng/ml) was added after 16-20-h serum depletion and total R.NA was 
cxtntctcd 4 h after rite stimul01rion. Polymerase chaiu rc:.1c tion using: 2 ~-tCi dCTP was 
performed as described in i\1m~:rit~ls amllvfetlwrls. Quan titative data (mean ::t SD) from 
three norma l skin fibroblast (NS) and 3 sclerodcrm11 fibroblast (SSe) strains were 
expressed as the ratio of incorporated r;ldio:lctiviry in respective G3PDH bands. 
b Values sigtliftcan tly greater than corrcsp011dil lg values without TGF-/31 sti mulation 
by Mann-Whitney's U tcsc, p < 0.05. 
served in sclerodenna fibroblasts involved induction by this PDGF-
like protein (CTGF). In the absence ofTGF-j31, the celllysates of 
both scleroderma and normal fibroblasts contained little PDGF-like 
protein, as shown by in1munoblotting ana lysis using polyclonal 
anti-PDGF antibody. In contrast, in the presence of 1 ng/ml of 
TGF-j31, the i11duction of 36-kD PDGF-tike protein was observed 
in both normal and scleroderma fi broblasts (Fig 2). The size of 
these proteins m atched that ofCTGF [7,15]. No bands identified as 
PDGF dimers (2 8 -30 kD) were observed in this experiment. T he 
amount of36-kD PDGF-like protein in sclerodem1a fibroblasts was 
3.5 ± 1.3-fold greater than that in control fibroblasts in the 
presen ce of TGF-j31, as measmed densitometrically (Fig 2). In 
parallel, we performed RT -PCR using primers specific for 
PDGF-A chain , PDGF-B chain , and CTGF. mRNA expression in 
HUVEC was also investigated as a contro l [7,12,13], and PDGF-A 
chain, PDGF-B cha.in, and CTGF transcripts were all observed in 
these cells. In contrast, no PDGF-A or-B mRNA was observed in 
scleroderma or normal fibroblasts . Although mRNA level ofCTGF 
was increased in both scleroderma and normal fibroblasts by 
TGF- J31 stimul ation, the exp ression of CTGF in scleroderma 
fibroblasts was 3.4-fold greater than that in normal fibroblasts in the 
presence of TGF-j31 (Fig 3, Table IV). 
DISCUSSION 
TGF-J3 has been implicated in the pathogenesis of SSe. This growth 
factor has a spectrum of connective tissue- and inflammatory 
cell-modulating activities that make tlus an attractive hypothesis 
[1] . Inflammatory cells are expected to release TGF-j3 into the 
surrounding milieu. Platelets, a rich source ofTGF-j31, arc known 
to show increased fragility and aggregation in SSe and may further 
contribute to the etiology of the disease. TGF- /3 is a multifunctional 
regulatory factor that acts as a potent growth inhibitor for most cells 
but can be mitogeni : to cells of mesenchymal origin through an 
autocrin e stimulatory mechanism. T here have been som e reports 
that TGF-J3 expression is increased in SSe lesions, especially in the 
earlier stages [16-18]. T hese studies suggest the early involvement 
of TGF-J3 in the progression of SSe following the cascade of otl1er 
growth factors. 
In contrast, PDGF is a good candidate for the cytokine involved 
in later stages of the progression of SSe. TGF-J3 is known to act 
synergisticall y with PDGF [19] and to induce PDGF-a receptor 
subunit expression on human dermal fibroblasts [6]. Because PDGF 
and TGF-J3 are contained in and simultaneously released fi·om 
platelets upon tissue damage, it seems like ly that the two factors 
may act in tandem, thus controlling, by their connected activities, 
the proliferation of fibroblasts in SSe. Moreover, we found that 
scleroderma fibrob lasts expressed increased densities of PDGF-Cl' 
receptors o n their surface in response to TGF-j31 [3) . The prolif-
erative response of sclerodem1a fibroblasts to PDGF-AA was 
correspondingly increased after exposure to TGF-/31. T hese results 
suggest that the increased expression of fibroblast populations in 
SSe may be due in part to activation of tl1e PDGF-AA ligand/ a 
receptor pathway. 
In tlus study we confirmed the increased mitogenic response to 
TGF-j31 in scleroderma fibroblasts that we reported previously [4]. 
ln the absence ofTGF-j31, both normal and scleroderma fibroblasts 
produced little 36-kD PDGF-like protein. Tlus production was 
enhanced in the presence of TGF-j31 especially in scleroderma 
fibroblasts, but we could not detect the e:-..-pression of PDGF itself 
(28-30 kD). Recently, a novel PDGF-like protein, a monomer of 
36-38 kD, was reported [7,15]. T lus protein has a 40% sequence 
homology to either the A orB chain ofPDGF and is termed CTGF; 
it was reported to be produced by human fibroblasts and by 
HUVEC [7]. We reported that TGF-J3 selectively induced intense 
CTGF mRNA expression in human foreskin fibroblasts, suggesting 
a cascade process for controlling fibroblast proliferation [15]. Tn this 
study, under stimulation by TGF-/31 , sclerodem1a fibroblasts did 
nor produce PDGF, but rather produced more 36-k.D PDGF-like 
protein than n orm al fibroblasts. It is likely that this 36-kD PDGF-
like protein is CTGF and that the increased response to TGF-/31 in 
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scleroderma fibrobla sts is m edia ted through the induction of 
CTGF, which was also confirmed by RT-PCR using specific 
primers for this transcript [7] . We also confirmed this upregulation 
of PDGF-a receptor in scleroderma fibroblasts in response to 
TGF-/31 . T his PDGF-a receptor/CTGF interaction may be another 
alteration that is important in the activation of fibrobla sts in SSe 
lesions. It is interestin g that scleroderma fibroblasts showed a 
greater response than controls to TGF-/31 through the induction of 
CTGF and PDGF-a receptor, although TGF-/31 is thought to be 
more abundant at least in earlier SSe lesions. These results suggest 
that a complex n etwork of growth regul ation by growth factors 
m ay play som e role in the pathogenesis of SSe and emphasizes the 
pivotal rol e of TGF-/3 in thi s network. 
T it is 1/IO rk rvns SllfJJJOrted i11 pm1 by n resenrclt grn111 jim11 rite Scleroder111a R esenrclt 
Co111111illee to rite Mi 11ist•T of Healtlt n11d JVeifnre, japn11 n11d n gra 111 for Sriwrific 
Rcsenrclt jro111 rite Mi11istry of Educntio11, Scie11cc nud C llifllrc, )npn11. 
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